Nofisat Ismaila

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2025

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2025

Transoral Robotic Surgery in the Multidisciplinary Care of Patiënten met Oropharyngeal Squamous Cell Carcinoma: ASCO ...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2025

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-04

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.3.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-04

Behandeling of Pleural Mesothelioma: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 maart 2025

Systemische therapie bij SCLC: ASCO 2025 snelle richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-01

NSCLC met driveralteraties: ASCO Living Guideline versie 2025.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 december 2024

Stadium III NSCLC: ASCO 2024 snelle richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2024

NSCLC met driveralteraties: ASCO Living Guideline versie 2024.2

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 juli 2024

Osteoradionecrose bij hoofd-halskankerpatiënten: preventie en management

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 juni 2024

NSCLC met driveralteraties: ASCO Living Guideline 2024.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

NSCLC zonder driveralteraties: ASCO Living Guideline 2024.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

Systemische therapie bij SCLC: ASCO-OH richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 december 2023

Stadium III NSCLC: ASCO 2023 snelle richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 september 2023

NSCLC met driveralteraties: ASCO Living Guideline versie 2023.3

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 mei 2023

NSCLC zonder driveralteraties: ASCO Living Guideline versie 2023.3

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 mei 2023

NSCLC met driveralteraties: ASCO Living Guideline versie 2023.2

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2023

NSCLC zonder driveralteraties: ASCO Living Guideline versie 2023.2

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2023

Stadium IV NSCLC zonder driveralteraties: ASCO Living Guideline versie 2023.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 februari 2023

Stadium IV NSCLC met driveralteraties: ASCO Living Guideline versie 2023.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 februari 2023

Biomarkers voor adjuvant endocriene en chemotherapie bij vroeg mammacarcinoom: ASCO 2022 richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 juni 2022

Stadium III NSCLC: ASCO 2022 richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 april 2022

Adjuvant bij volledig gereseceerd stadium I-IIIA NSCLC: ASCO 2022 richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 april 2022

Speekselkliermaligniteiten: ASCO 2021 richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 juni 2021

Chemotherapie plus RT bij stadium II-IVA nasofarynxcarcinoom: ASCO richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 maart 2021

Longkankersurveillance na curatieve therapie: ASCO 2020 richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 maart 2020

Behandeling van multipel myeloom: ASCO/CCO 2019 gezamenlijke richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 mei 2019

Initiële diagnostiek bij acute leukemie: ASCO onderschrijving CAP/ASH richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2019

Behandeling van maligne pleuramesothelioom: ASCO richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 mei 2018

Larynxbehoudstrategieën bij larynxcarcinoom: ASCO richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2018

Botmodificerende middelen bij multipel myeloom: ASCO richtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 maart 2018

Biomarkers voor adjuvante therapiebeslissingen bij vroeg mammacarcinoom: ASCO klinische praktijkrichtlijn update

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2017

Behandeling van kleine niertumoren: ASCO klinische praktijkrichtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 februari 2017

HER2-testen en klinische besluitvorming bij gastro-oesofageaal adenocarcinoom: CAP/ASCP/ASCO richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017-02

Radiotherapie bij glioblastoom: ASCO-onderschrijving van de ASTRO evidence-based richtlijn

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 januari 2017

Biomarkers voor besluitvorming over adjuvante systemische therapie bij vroegstadium invasief mammacarcinoom

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 april 2016